Illumina, Inc. ILMN is set to release fourth-quarter 2025 results on Feb. 5, after the closing bell. The company posted ...
Study shows that rare variants captured by Illumina WGS with DRAGEN™ variant calling explain most of the "missing heritability" in complex human diseases and traits, including those related to blood ...
The Illumina Campus in San Diego. (File photo courtesy of the company) Illumina said Wednesday the Chinese Ministry of Commerce will lift its ban on imports of the San Diego company’s gene sequencers ...
China is set to ease restrictions on some Illumina products, giving the sequencing giant a partial reprieve. Since March, Illumina has been barred from exporting its DNA sequencers to China, after ...
Illumina Inc. said the Chinese government has lifted a ban on the company selling its DNA sequencing machines inside the country. The move is a reversal from China’s previous position, which blocked ...
10x Genomics’ facility at 5500 Stoneridge Mall Road Pleasanton, CA, one of the company’s three sites in the San Francisco suburb. 10x Genomics has joined with two licensor partners to administer a ...
This week, the Broad Institute gene-sequencing lab said it read infants’ DNA genomes in less than four hours, cutting an hour off the previous Guinness World Record. The point for investors is that ...
A pair of presentations at this year’s annual meeting of the American Society of Human Genetics highlighted some of the latest capabilities from sequencing giant Illumina. At the meeting, the company ...
Taiwan-based gene sequencing company Genomics BioSci & Tech has entered a strategic partnership with global sequencing leader Illumina to jointly promote gene sequencing and multi-omics technologies ...
Sept 22 (Reuters) - Life sciences company Element Biosciences sued Illumina (ILMN.O), opens new tab on Monday in separate cases in federal courts in California and ...
Shenzhen-based MGI Tech unveiled what it claims to be the world's fastest gene sequencer, an advance that promises to help accelerate breakthroughs in cancer genomics and rare disease research. The ...